1 / 35

Nonimmune hydrops hemorrhagic diseases of the newborn

William 2001. Nonimmune hydrops hemorrhagic diseases of the newborn. Hyperbilirubinemia Nonimmune hydrops Cardiac arrhythmias Hemorrhagic disease of the newborn Thrombocytopenia Polycythemia Necrotizing entrocolitis. Unconjugated bilirubin : Not excreted in bile and urine

ranger
Download Presentation

Nonimmune hydrops hemorrhagic diseases of the newborn

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. William 2001 Nonimmunehydropshemorrhagic diseases of the newborn

  2. Hyperbilirubinemia • Nonimmunehydrops • Cardiac arrhythmias • Hemorrhagic disease of the newborn • Thrombocytopenia • Polycythemia • Necrotizing entrocolitis

  3. Unconjugatedbilirubin: • Not excreted in bile and urine • Pass the placenta to the mother Conjugated bilirubin: • Water soluble • Excreted in bile and urine Kernicterus: ↑ unconjugatedbilirubin > 18 – 20 mg/dL - < 18 in preterm hyperbilirubinemia

  4. Clinical picture: • Spasticity • MR • Muscle incoordination Causes of kernicterus: • Hypoxia • Hypoglycemia • hypothermia • Acidosis • sepsis

  5. Drugs: Furosemide Gentamicin Salicylates Sulfonamides Diazepam Na benzoate ↑ vitamin K1

  6. Brest milk jaundice: - Due to excretion of: pregnane – 3 α, 20 β–diol in the milk  inhibit conjugation of bilirubin by inhibiting glucuronyltransferase activity - Jaundice starts 4th to 15th day - No encephalopathy

  7. Physiological jaundice: Starts 3rd to 4th day Bilirubin level < 10 mg/dL Phototherapy: For treatment of hyperbilirubinemia Mechanism: Ligh oxidation of bilirubin  ↓  ↑ peripheral blood flow  ↑ photooxidation

  8. Method: • Eyes covered • Skin exposed • Appropriate fluorescent wavelength • Baby turned /2 hours • Bilirubin measured after 24 hours • Monitor temperature to prevent dehydration

  9. Definition: Abnormal fluid accumulation in ≥ sites Incidence: 0.6 %  77% of them are known 1.7 %  95% of them are known Incidence of hydrops: 13% immune 1.3% extrinsic 21% idiopathic 64% intrinsic Nonimmunehydropsfetalis

  10. Intrinsic causes: 41% cystic hygroma 27% cardiac anomalies 21% multiple malformations 11% others Causes of nonimmunehydrops: 1 – Cardiac: = 20 – 45%

  11. ½ structural anomalies ½ cardiac arrhythmia 2 – Chromosomal anomalies: = 35% - earlier - extensive  space suite hydrops 87% with anencephaly 3 – Severe anemia: Parvovirus Acute fetal - maternal Hg α - thalassemia

  12. 4 – Twin-to-twin transfusion: Recipient  HF Donor  hydrops after the death of the recipient 5 - Inborn errors of metabolism: - Gaucher disease - GM 1 gangliosidosis - Sialidosis All  recurrent hydrops

  13. 6 – Lymph system anomalies: - Chylothorax - Chylousascites Prognosis: < 24 weeks  95% mortality ≥ 24 weeks  80% mortality Diagnosis: Maternal tests – cordocentesis - US

  14. Maternal tests: • Hb electrophoresis • Indirect Coombs test • Kleihauer – Batke test • Serological tests for: Rubella Toxoplasmosis Syphilis Cytomegalovirus Parvovirus B - 19

  15. Cordocentesis: • karyotyping • Hb% • Hb electrophoresis • Direct Coombs test • Liver transaminases • Serological test for Ig M specific Abs

  16. Most important predictor tests for prognosis: • Karyotyping • Fetal ECG Management: - Blood transfusion for anemia - Amniocentesis for twin-to-twin transfusion may  spontaneous cure If persistent  exclude cardiac anomalies and anencephaly

  17. Deliver if near term Expectant treatment if very preterm Maternal complications: • Mirror syndrome: Edema and preeclampsia due to vascular changes in the fetus • Others: Overdistension  PTL – PP Hg -- retained placenta

  18. Usually transient and benign Some tacchycardia if sustained may  hydrops, HF and fetal death Sustained bradicardia is caused by: • Congenital anomalies • Myocarditis And is less often associated with hydrops Cardiac arrhythmias

  19. Isolated extrasystoles: • Atrialextrasystoles • Ventricular extrasystoles Sustained arrhythmias: • Supraventriculartacchycardia • Ventricular tacchycardia • Complete heart block • 2 degree heart block • Atrial flatter, fibrillation • Sinus bradicardia Types of arrhythmias

  20. Premature atrial contractions: = 64% of cardiac arrhythmia Usually benign and transient Rarely  supraventricular tacchycardia and if > 200 b/m may  HF Bradicardia:  Poor prognosis Caused by:

  21. Structure anomalies as A-V canal • Heart block Congenital heart block: - Caused by Abs against fetal myometrium in 50% of the cases - Most common Abs: Anti-SS-A (Anti Ro) Abs -  Inflammation and permanent damage to the myocardial tissue

  22. - Neonate may require pacemaker - Only 1 : 20 of the cases are affected - Mothers usually have: SLE or other CT disease or subsequently develop it Fetotherapy : By corticosteroids to the mother

  23. Characterized by: • Hypoprothrombinemia • ↓ factor V, VII, IX, X • ↑ prothrombin time • ↑ PTT  Spontaneous internal or ext Hgs May occur at any time Usually delayed 1 – 2 days Hemorrhagic disease of the neonate

  24. Causes: • ↓ vit k1 • Hemophilia • Sepsis • Syphilis • Thrombocytopenia • Erythroblastosis • ICH

  25. Vit K1: • ↓ during pregnancy # nonpregnant • ↓ placental transmission • ↓ in milk Anticonvulsive drugs prevent hepatic synthesis of factor VII, IX, X  ↓ vit K1  A phenotype similar to Chondrodysplasia punctata = Conradi – Hunermann syndrome =inherited disease characterized by bone dystrophy and facial anomalies

  26. Types: 1 – Immune thrombocytopenia: - Maternal antiplateletIg G  fetal/ neonatal thrombocytopenia - Usually associated with maternal autoimmune disease and maternal thrombocytopenia - Corticosteroid therapy  ↑ maternal platelet count but does not improve fetal condition thrombocytopenia

  27. 2 -- Alloimmune thrombocytopenia (ATP): - Fetal platelet Ag  pass the placenta to the mother  isoimmunization - Usually discovered after the delivery of an affected child - May  IC Hg - 98% of the population are HPA 1a +ve 2 % of the population are HPA 1a –ve - % = 1 : 5000 – 10000 live birth - 1 : 50 of pregnancies are at risk

  28. - Significant fetal – maternalHg must occur provoke immune respond - Affect offspring of women with HLA type DR - 3 or B - 8 Diagnosis: - Maternal platelet count normal +no autoimmune disease - Fetal platelets count ↓ + no other autoimmune D

  29. - IV injection of Ig in a large dose to the mother  recurrent fetal thrombocytopenia by cordocentesis Recurrence = 70 – 90%  More severe and earlier in subsequent pregnancies

  30. Predisposing factors: • Chronic hypoxia • Placentaltransfusion ( maternal or twin) Clinical picture: • Plethora • Cyanosis • Neurological impairment polycythemia

  31. Laboratory: • ↑ bilirubin • ↓ platelet • Hypoglycemia • Fragmented RBCs Treatment: plasma

  32. Bowel disorder affects mainly premature neonates due to intestinal immaturity Clinical picture: • Distension • Illus • Bloody stools X ray: Gas in intestine = pneumatosisintestinalis May  perforation Necrotizing enterocolitis

  33. % 5.7of preterm infants Causes: • Perinatal hypotension • hypoxia • Sepsis • Umbilical catheters • Exchange transfusion • Hypertonic fluids

  34. Cow milk • Coronovirusinfection Treatment: Ig administration orally

More Related